Customers
AuraScore 83/100

Clinical Trial Participant Retention Email Notification Specification

Develop a multi-visit trial retention email workflow specification for decentralized and hybrid clinical studies.

Use this template when setting up patient communication automation for clinical trial sites. It structures protocol-aligned visit reminders, milestone encouragements, and safety survey notifications to reduce participant drop-out rates.

Template

Role: Principal Clinical Patient Engagement Lead and Decentralized Trial Operations Architect.

Context

  • Clinical Trial Phase: {{trial_phase}}
  • Therapeutic Area: {{therapeutic_area}}
  • Protocol Identifier: {{protocol_id}}
  • Participant Population Criteria: {{patient_population_criteria}}
  • Privacy and Consent Standard: {{data_privacy_standard}}
  • Known Retention Risk Factors: {{retention_risk_factors}}

Task

Produce an operational email communication specification for participants enrolled in {{protocol_id}}, establishing automated schedule reminders, electronic Patient-Reported Outcomes (ePRO) prompts, and site contact touchpoints to mitigate participant attrition.

Method

  1. Review {{retention_risk_factors}} to pinpoint protocol drop-out hazard points across {{trial_phase}} milestones.
  2. Construct the participant communication schedule spanning baseline visit to final study closeout.
  3. Draft granular message specifications for five core triggers: Pre-Visit Logistics, Post-Visit Gratitude & Debrief, ePRO Completion Alert, Diary Non-Compliance Warning, and Trial Milestone Recognition.
  4. Design communication safeguards for blinding and masking rules required by {{therapeutic_area}} protocols.
  5. Define dynamic personalization fields while maintaining strict pseudonymization under {{data_privacy_standard}}.
  6. Outline site-level override capabilities enabling Principal Investigators to pause or modify sequences during adverse events.
  7. Establish delivery verification, bounce-handling protocols, and unengaged participant escalation paths.

Constraints

  • MUST NOT unblind randomized cohorts or reference investigational arm details in unencrypted email bodies.
  • MUST remain strictly aligned with Institutional Review Board (IRB) and Ethics Committee communication boundaries.
  • Language must maintain neutral, non-coercive framing avoiding promotional claims about experimental outcomes.
  • All site coordinator contact details and unsubscription pathways must be explicit in every message template.

Output format

Deliver the document divided into the following mandatory sections:

  1. Communication Schedule & Protocol Milestone Map.
  2. Message Specifications (5 detailed notification specs including triggers, copy drafts, and token catalogs).
  3. Privacy, Anonymization & IRB Boundary Checklist under {{data_privacy_standard}}.
  4. Site Coordinator Escalation & Exception Handling Procedures. Target length is 900 to 1,300 words.

Self-review

  • Are all participant communications neutral and strictly non-coercive?
  • Does the specification fully protect blinding protocols for {{protocol_id}}?
  • Are fallback channels defined if automated emails fail delivery during critical ePRO windows?
AuraScore breakdown
83/100Provisional
Instruction clarity15/15 · Strong

Explicit role, a named task, and discrete steps the model can follow.

Context architecture12/12 · Strong

Background, inputs and variables the model needs before it starts.

Constraint engineering12/12 · Strong

Hard boundaries — what the model must and must not do.

Output specification6/14 · Thin

A named, field-level shape for the response.

Reasoning structure10/10 · Strong

Ordered work items that force analysis before an answer.

Model compatibility10/10 · Strong

Length and structure that travel across frontier models.

Token efficiency5/10 · Thin

Signal density — instruction weight without padding.

Reusability7/7 · Strong

Documented variables so the scaffold adapts to new inputs.

Robustness5/5 · Strong

Quality bar, assumptions and behaviour when inputs are thin.

Observed performance1/5 · Thin

How much real usage the template has behind it.

emails
emails-customers
healthcare-life-sciences
clinical-trials
patient-retention
trial-operations